In a significant move within the Indian healthcare sector, the 360 ONE Asset management firm is set to facilitate a major hospital stake buyback. Specifically, they will lend approximately ₹600 crore to Narendra Pandey, the founder of the Asian Institute of Medical Sciences (AIMS). This funding enables the repurchase of a 49% stake currently held by British International Investment and OrbiMed. Consequently, Pandey will consolidate his ownership of the Faridabad-based 450-bed hospital. This transaction highlights the growing reliance on private credit for ownership consolidation in India.

Dynamics of the Hospital Stake Buyback

The deal values the hospital at around ₹1,200 crore. Previously, the private equity investors attempted to sell their stakes to other firms. However, those efforts failed due to high valuation expectations. Therefore, Pandey chose to explore structured credit solutions to regain control. This trend is becoming increasingly common among Indian promoters. Furthermore, the healthcare delivery sector remains robust, with standalone hospitals often fetching high valuations based on earnings. As a result, founders are keen to maintain their equity before potentially pursuing public listings.

Implications for Healthcare Delivery

Consolidation of ownership allows founders to maintain their long-term vision for clinical excellence. In particular, the AIMS founder's decision reflects confidence in the hospital's growth potential. Private credit platforms like 360 ONE now play a pivotal role in such transactions. Additionally, this shift indicates a maturing financial ecosystem for Indian healthcare providers. Moreover, many companies with IPO ambitions prefer this route to streamline their capital structure. Lastly, we are seeing more structured debt deals across various sectors in India.

Frequently Asked Questions

Q1: Who is financing the AIMS stake buyback?

360 ONE Asset is expected to lend about ₹600 crore to facilitate the transaction for the AIMS founder.

Q2: What is the estimated valuation of AIMS hospital in this deal?

The 450-bed multispecialty hospital is expected to be valued at approximately ₹1,200 crore.

Q3: Why did the previous sale of the stake fail?

Previous attempts to sell the stake to other private equity investors reportedly failed due to high valuation expectations from the sellers.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. 360 ONE to finance AIMS founder's stake buyback - ETHealthworld


2. EY Report: Indian Transaction Trends and Private Credit Growth 2025.


3. Healthcare Delivery Sector in India: Market Valuation Analysis 2026.